Coming Soon
Find information on Cannabis Abuse (Marijuana Abuse, Cannabis Use Disorder) diagnosis, including clinical documentation, medical coding, and healthcare resources. Learn about symptoms, diagnostic criteria, and treatment options for Cannabis Use Disorder. This resource provides support for accurate medical coding and comprehensive clinical documentation related to CUD in healthcare settings.
Also known as
Cannabis abuse
Harmful use of cannabis.
Cannabis dependence
A cluster of behavioral, cognitive, and physiological phenomena.
Cannabis use, unspecified
Cannabis use where the type of use is not specified.
Cannabis use
Contact with and (suspected) exposure to cannabis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the cannabis use causing clinically significant impairment or distress?
When to use each related code
| Description |
|---|
| Problematic cannabis use leading to impairment. |
| Cannabis dependence with withdrawal or tolerance. |
| Cannabis-induced psychosis or anxiety. |
Coding cannabis abuse requires distinguishing between abuse and dependence. Incorrect coding can impact reimbursement and quality metrics.
Insufficient documentation of frequency, duration, and impact of cannabis use can lead to coding errors and denials.
Cannabis abuse often co-occurs with mental health disorders. Accurate capture of all diagnoses is crucial for appropriate care and reimbursement.
Q: What are the most effective evidence-based interventions for adolescent cannabis use disorder in primary care settings?
A: Addressing adolescent cannabis use disorder (CUD) in primary care requires a multi-pronged approach. Screening tools like the CRAFFT are crucial for early identification. Motivational interviewing (MI) and brief interventions tailored to the adolescent's stage of development can enhance engagement and promote behavior change. Cognitive behavioral therapy (CBT) and family-based interventions have demonstrated efficacy in reducing cannabis use and improving overall functioning. Consider implementing Screening, Brief Intervention, and Referral to Treatment (SBIRT) protocols, which are particularly suited for primary care settings. Explore how integrating these evidence-based interventions can enhance your practice's effectiveness in managing adolescent CUD. For complex cases or those requiring higher levels of care, referral to specialized addiction treatment programs is recommended.
Q: How can clinicians differentiate between cannabis-induced psychosis and primary psychotic disorders in patients presenting with acute psychotic symptoms?
A: Differentiating cannabis-induced psychosis (CIP) from primary psychotic disorders like schizophrenia can be challenging due to overlapping symptoms. A thorough clinical evaluation, including a detailed history of cannabis use (frequency, potency, duration), family history of psychosis, and premorbid functioning, is essential. CIP typically presents with acute and transient psychotic symptoms, often closely temporally related to cannabis use. In contrast, primary psychotic disorders may have a more insidious onset and persist even in the absence of cannabis. Careful observation of symptom resolution after a period of abstinence from cannabis can be informative. Consider implementing standardized assessment tools, like the Brief Psychiatric Rating Scale (BPRS), to track symptom changes. Learn more about the specific diagnostic criteria for CIP and primary psychotic disorders to enhance diagnostic accuracy and ensure appropriate treatment. Referral to a psychiatrist specializing in psychosis may be necessary for complex or uncertain cases.
Patient presents with symptoms consistent with Cannabis Use Disorder (CUD), also known as marijuana abuse or cannabis abuse. The patient reports a problematic pattern of cannabis use leading to clinically significant impairment or distress, as manifested by at least two of the following criteria within a 12-month period: cannabis is often taken in larger amounts or over a longer period than was intended; there is a persistent desire or unsuccessful efforts to cut down or control cannabis use; a great deal of time is spent in activities necessary to obtain cannabis, use cannabis, or recover from its effects; craving, or a strong desire or urge to use cannabis; recurrent cannabis use resulting in a failure to fulfill major role obligations at work, school, or home; continued cannabis use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of cannabis; important social, occupational, or recreational activities are given up or reduced because of cannabis use; recurrent cannabis use in situations in which it is physically hazardous; cannabis use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by cannabis; tolerance, as defined by either a need for markedly increased amounts of cannabis to achieve intoxication or desired effect or a markedly diminished effect with continued use of the same amount of cannabis; and withdrawal, as manifested by either the characteristic withdrawal syndrome for cannabis or cannabis is taken to relieve or avoid withdrawal symptoms. The patient's cannabis use impacts their daily functioning and causes significant distress. Differential diagnoses considered include other substance use disorders and mood disorders. Treatment recommendations include motivational interviewing, cognitive behavioral therapy (CBT), and contingency management. The patient will be monitored for treatment adherence and progress. ICD-10 code F12.20 will be used for billing and coding purposes. Follow-up appointment scheduled in two weeks to assess treatment response and address any emerging needs.